View in EDS HTML Full Text PDF Full Text

Editorial comment on "Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety (TATE study)".

Saved in:
Bibliographic Details
Title: Editorial comment on "Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety (TATE study)".
Authors: Cabrera‐Perez, Javier S.1 (AUTHOR), Eigenmann, Philippe2 (AUTHOR), Akenroye, Ayobami1 (AUTHOR) aakenroye@bwh.harvard.edu
Source: Pediatric Allergy & Immunology. Apr2024, Vol. 35 Issue 4, p1-3. 3p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09056157
DOI:10.1111/pai.14128